This site is intended for health professionals only

Published on 27 July 2011

Share this story:
Twitter
LinkedIn

Vitamin D ‘relieves pain for breast cancer patients’

teaser

High-dose vitamin D relieves joint and muscle pain for many breast cancer patients taking oestrogen-lowering drugs, according to a new study published in Breast Cancer Research and Treatment.

The drugs, known as aromatase inhibitors, are commonly prescribed to shrink breast tumours fuelled by the hormone oestrogen and help prevent cancer recurrence.

They are less toxic than chemotherapy, but for many patients the drugs may cause severe musculoskeletal discomfort, including pain and stiffness in the hands, wrists, knees, hips, lower back, shoulders and feet.

“About half of patients can experience these symptoms,” said Antonella Rastelli, Assistant Professor of Medicine at Washington University School of Medicine and lead author of the study.

“We don’t know exactly why the pain occurs, but it can be very debilitating — to the point that patients decide to stop taking aromatase inhibitors.”

Because the drugs reduce cancer recurrence, finding a way to help patients stay on them is important for long-term, relapse-free survival, according to Rastelli.

Aromatase inhibitors are prescribed to post-menopausal women for at least five years and often longer after a breast cancer diagnosis. There is some evidence that patients who experience the drugs’ side effects are less likely to see their cancer return, providing even more incentive to help these patients continue taking them.

Rastelli’s group recruited 60 patients with low vitamin D levels who reported pain and discomfort associated with anastrozole, one of three FDA-approved aromatase inhibitors.

Half the group was randomly assigned to receive the recommended daily dose of vitamin D (400 international units) plus a 50,000-unit vitamin D capsule once a week.

The other half received the daily dose of 400 units of vitamin D plus a weekly placebo. All subjects received 1,000 milligrams of calcium daily throughout the study.

Patients in the study reported any pain they experienced through three different questionnaires. They were asked to quantify their pain intensity and report how much the pain altered their mood, affected their work and interfered with relationships and daily activities.

The results show that patients receiving high-dose vitamin D every week reported significantly less musculoskeletal pain and were less likely to experience pain that interfered with daily living.

“High-dose vitamin D seems to be really effective in reducing the musculoskeletal pain caused by aromatase inhibitors,” said Rastelli.

“Patients who get the vitamin D weekly feel better because their pain is reduced and sometimes goes away completely.
This makes the drugs much more tolerable. Millions of women worldwide take aromatase inhibitor therapy, and we may have another ‘tool’ to help them remain on it longer.”

Like anastrozole used in this study, the other two FDA-approved aromatase inhibitors, letrozole and exemestane, also cause musculoskeletal pain. Given the similar side effects, Rastelli said patients on these drugs might also benefit from high-dose vitamin D.

The vitamin used in this study is a plant-derived type called vitamin D2. Rastelli says it achieves the best results when given weekly because the body metabolizes it within seven to 10 days. Rastelli and her colleagues did not use high-dose vitamin D3, which remains in the body longer.

Since vitamin D helps the body absorb calcium, too much of it can cause high levels of calcium in the urine, which may increase the risk of kidney stones. Such possible side effects emphasize the importance of tracking patients’ urine calcium levels while taking high-dose vitamin D.

“It’s important to monitor the patients, but overall it appears to be very safe,” said Rastelli.

“Because vitamin D2 is eliminated from the body so quickly, it’s very hard to overdose.”

In addition to relieving pain, the group wanted to examine whether vitamin D could protect against the bone loss often seen in patients taking aromatase inhibitors. The researchers measured each patient’s bone density at the beginning of the study and again after six months.

Perhaps because of its role in calcium absorption, high-dose vitamin D did appear to help maintain bone density at the neck of the femur. Although the result did not reach statistical significance, Rastelli called the result promising and worth further studies.

“It’s great that we have something as simple as vitamin D to help patients alleviate some of this pain,” Rastelli said.

“It’s not toxic, it doesn’t cause major side effects, and if it’s actually protecting against bone loss, that’s even better.”



Most read




Latest Issue

Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Share this story:
Twitter
LinkedIn